Novo Nordisk (NVO) intends to reduce its global workforce by about 9,000 of the 78,400 positions in the company, with around 5,000 reductions expected in Denmark, the obesity drugmaker said on ...

Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in the obesity market. The Danish company has been battling it out with US ...

Wegovy-maker Novo Nordisk will cut 9,000 jobs, or about 11.5% of its workforce, in a restructuring to save $1.26 billion annually, it said on Wednesday, as it battles rising pressure from US rival Eli ...

Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company’s focus on growth ...

Novo Nordisk NOVO.B-1.51%decrease; red down pointing triangle said it would cut around 9,000 jobs, as its new chief executive tries to revive the drugmaker’s fortunes in the booming weight-loss market ...

Novo Nordisk - makers of Ozempic - is set to lay off 9,000 staff members, or 11.5 % of its workforce. Five thousand of the cuts will come from its locations in Denmark. Charlie Kirk dead at 31 Wild ...

The company, one of Bloomington’s major employers, did not comment on whether any jobs at its Bloomington campus would be cut. “This is a global transformation, and each country, site or region will ...

Weight-loss drugmaker to cut 11.5% of staff 5,000 job cuts in home country of Denmark Expects annual savings of $1.3 billion Will boost performance-based culture, CEO says Shares up 2.1% The ...

The maker of the popular weight-loss drug Wegovy announced on Wednesday that it will be cutting 9,000 jobs in the company. Novo Nordisk said a majority of the jobs lost, 5,000 of them, will be in ...

Novo Nordisk, the maker of in-demand drugs Ozempic and Wegovy, said it will cut thousands of global jobs to simplify operations and reallocate resources toward its diabetes and obesity drugs as rivals ...